InnovHeart Revenue and Competitors

Milano,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • InnovHeart's estimated annual revenue is currently $10.3M per year.(i)
  • InnovHeart's estimated revenue per employee is $251,000

Employee Data

  • InnovHeart has 41 Employees.(i)
  • InnovHeart grew their employee count by 5% last year.

InnovHeart's People

NameTitleEmail/Phone
1
CTOReveal Email/Phone
2
VP, Clinical AffairsReveal Email/Phone
3
VP Quality AssuranceReveal Email/Phone
4
Director Field Clinical EngineeringReveal Email/Phone
5
Sr. Director, R&D, Mitral Valve (TMVR) Delivery SystemReveal Email/Phone
6
R&D DirectorReveal Email/Phone
7
Office Manager, HR & LogisticsReveal Email/Phone
8
Clinical Development Engineering ManagerReveal Email/Phone
9
Finance ManagerReveal Email/Phone
10
Finance ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is InnovHeart?

InnovHeart s.r.l., with locations in Milan, Italy and Poway, Calif, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease. The Company is in late preclinical development of its novel TMVR Saturn Prosthesis, designed to be consistent with the anatomy of the mitral valve and, currently, in development as a Transapical as well as a Transeptal system. InnovHeart is backed by leading investor Genextra S.p.A, Italian based holding company specialized in early-stage investments in the life sciences sector.

keywords:N/A

N/A

Total Funding

41

Number of Employees

$10.3M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

InnovHeart News

2022-03-22 - InnovHeart appoints David Wilson as Chief Executive Officer

NEWTON, Mass., March 30, 2022 /PRNewswire/ -- InnovHeart s.r.l., a developer of the novel Saturn Transcatheter Mitral Valve Replacement...

2022-03-22 - 4C Medical scores $35M and a new CEO to advance TMVR tech

... Medtronic, InnovHeart and more—are doing so by developing implants that are placed directly within a faulty mitral valve to keep blood...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.7M418%N/A
#2
$7.2M41-11%N/A
#3
$8.2M41-7%N/A
#4
$4.9M42-11%N/A
#5
$6.9M42-2%N/A